Elizabeth
Analyst
Goldman Sachs
Equibles does not estimate personal net worth.
About Elizabeth
Elizabeth is recorded as Analyst at Goldman Sachs. Elizabeth has spoken on 2 earnings calls across 2 companies, most recently for Taysha Gene Therapies, Inc. on November 12, 2026. Those appearances were for Taysha Gene Therapies, Inc. (TSHA) and Moderna, Inc. (MRNA). The companies whose calls Elizabeth spoke on are classified in the Healthcare sector.
Elizabeth on recent calls
“You mentioned that you will nominate an additional candidate targeting a CNS disorder and start preclinical activities in the first half of next year.”
“We wanted to ask about the flu and COVID combination vaccine and just given the RTF-41010, how should we think about this refiling and is there any read-through from a regulatory standpoint in the U.S. and then maybe just remind us of the study data that went into the submission initially and what the latest thinking…”
Affiliation history
-
Goldman Sachs
Analyst
Transcript header (unverified)
Current
Company network
Moderna, Inc.
MRNA
Biotechnology · Healthcare
1 appearance
Latest appearance 2026-02-13
View calls and events